Hemp Industries Association Responds To DEA Final Rule Regarding ‘Marijuana Extracts’

DOJ/DEA Extracts Code

DISTRICT OF COLUMBIA:  The Hemp Industries Association (HIA), the leading non-profit trade association consisting of hundreds of hemp businesses, has issued its position in response to a recent DEA ruling, submitted to the Federal Register December 14, 2016, which seeks to establish a new drug code for ‘marijuana extract.’ Specifically, the DEA has proposed that CBD, Read the full article…

Federal Marijuana Protections Extended Through April

MJ_Legal

DISTRICT OF COLUMBIA: Members of Congress have re-authorized a federal provision prohibiting the Justice Department from interfering in state-authorized medical cannabis programs. The provision, known as the Rohrabacher-Farr amendment, was included in short-term spending legislation, House Resolution 2028, and will expire on April 28, 2017. Initially enacted by Congress in 2014, the amendment maintains that federal funds Read the full article…

DEA Hurts Growing Industry; Enacts Final Rule Seeking To Make Any Extract Of Cannabis Plant Schedule 1 Drug

The DEA goes after CBD

By Bob Hoban, Managing Partner – Hoban Law Group On December 13, 2016, the DEA issued its Final Rule, “Establishment of New Drug Code for Marihuana Extract,” which serves to potentially devastate developing businesses and consumer, textile and manufacturing industries related to cannabinoids. Robert Hoban, a cannabis, cannabinoid and hemp lawyer and expert as well as Read the full article…

Ninth Circuit Rules Marijuana Card Holders May Not Own Firearms

MJ_Legal

NEVADA: Last Wednesday a three-judge panel of the Ninth Circuit Court of Appeals upheld a lower court’s decision that holding a marijuana card precludes its owner from keeping and bearing arms. In the process, the panel threw out the First, Second, and Fifth Amendment rights. Rowan Wilson, a Nevada resident who held a state-issued marijuana card but Read the full article…

Former Deputy Attorney General James Cole Reflects Back On The Cole Memos

James Cole looks back on the "Cole Memo"

NEW YORK: Pot podcaster Cannabis Economy has released an in-depth interview with Former US Deputy Attorney General James M. Cole whose three memos reset Justice Department guidance regarding federal oversight of legal cannabis.  The conversation is Episode 140 on the Cannabis Economy podcast app on iTunes, Google Play or found through the iTunes Podcast App. “You can’t prosecute every case involving Read the full article…

Federal Reclassification Of Marijuana Could Have Major Impact On Medical Uses

The DEA along with the U.S. Department of Health and Human Services and Office of National Drug Control Policy announced they would review marijuana's classification after multiple letters from senators last year, including Sen. Elizabeth Warren, D-Massachusetts, and Sen. Kirsten Gillibrand, D-New York.l

DISTRICT OF COLUMBIA: Federal authorities have announced that they are reviewing the possibility of loosening the classification of marijuana, and if this happens, it could have a far-reaching impact on how the substance is used in medical settings, experts said. Marijuana is currently classified as a Schedule I drug, meaning it is listed alongside heroin Read the full article…

New Rules On Medical Marijuana Research Could Play Into Pennsylvania Legislative Process

These modifications will streamline the research process regarding CBD’s possible medicinal value and help foster ongoing scientific studies.

PENNSYLVANIA:  Last week the U.S. Drug Enforcement Administration relaxed regulations on medical marijuana research, with potential implications for approval of laws in Pennsylvania. Loosening regulations on medical marijuana research should streamline the process for researchers conducting FDA-approved clinical trials on cannabidiol, or CBD, an extract of the marijuana plant, according to a news release from Read the full article…

DEA Eases Requirements For FDA-Approved Clinical Trials On Cannabidiol

These modifications will streamline the research process regarding CBD’s possible medicinal value and help foster ongoing scientific studies.

WASHINGTON: The United States Drug Enforcement Administration (DEA) recently eased some of the regulatory requirements imposed by the Controlled Substances Act (CSA) for those who are conducting FDA-approved clinical trials on cannabidiol (CBD), an extract of the marijuana plant.  These modifications will streamline the research process regarding CBD’s possible medicinal value and help foster ongoing scientific studies. Read the full article…

The DEA Has Failed To Eradicate Marijuana. Some Members Of Congress Want It To Stop Trying.

DISTRICT OF COLUMBIA: The Drug Enforcement Administration is not having a great year. The chief of the agency stepped down in April under a cloud of scandal. The acting administrator since then has courted ridicule for saying pot is “probably not” as dangerous as heroin, and more recently he provoked 100,000 petition-signers and seven members of Congress to call for his Read the full article…

Medical Marijuana Patients To DEA Chief: Pot Is No ‘Joke,’ And You Should Be Fired

mmj is no joke

DISTRICT OF COLUMBIA: Medical marijuana patients and advocates on Friday delivered a petition to Drug Enforcement Administration headquarters in Arlington, Virginia, calling for the firing of DEA chief Chuck Rosenberg for his characterization that using the drug as medicine was “a joke.” The petition, signed by more than 100,000 people, calls on President Barack Obama to oust Rosenberg Read the full article…